5921 - 5930 of 8808 Results
Title
Year
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 30
-
RESTRICTEDTitle: Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2419End Page: 2425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28712Citation Count: 22
- Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial2021RESTRICTEDTitle: Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2693End Page: 2698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28759Citation Count: 26
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 22
-
OPENTitle: Parkinson's Disease and COVID‐19: Do We Need to Be More Patient?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 277End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28469Citation Count: 12
-
RESTRICTEDTitle: Access and Attitudes Toward Palliative Care Among Movement Disorders CliniciansJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 182End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28773Citation Count: 30
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 38
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021RESTRICTEDTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 40
-
OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/dc04516a-d43f-4a65-914b-0c5d09b9e5d8Citation Count: 25
- Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease2021OPENTitle: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 490End Page: 501Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28886Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940677Citation Count: 14